Evaluating DDR Combinations in the Clinic: Promises, Pitfalls, Challenges

Time: 2:30 pm
day: Day Two


  • DDR combinations have shown promising synergistic activity in preclinical studies
  • Challenges in overlapping toxicity have hampered the development of different DDR combinations
  • Novel agents and clinical trial designs are needed to be implemented to overcome such challenges